Skip to content

Medication-Assisted Treatment Implementation in Community Correctional Environments (MATICCE)

Medication-Assisted Treatment Implementation in Community Correctional Environments (MATICCE)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01344122
Acronym
MATICCE
Enrollment
20
Registered
2011-04-28
Start date
2010-10-31
Completion date
2013-09-30
Last updated
2014-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol-Related Disorders, Opioid-Related Disorders

Brief summary

The goal of this study is to see whether or not a strategic planning process is able to introduce and sustain improvements in the working relationship between probation/parole departments and community-based addiction treatment agencies that provide medication assisted therapy (MAT) for individuals with opioid or alcohol dependence. In addition, this study seeks to improve probation/parole agency personnel's knowledge and perceptions about MAT, and increase the number of appropriate referrals to community treatment agencies that provide MAT. There are three phases to this study. Phase 1 includes a pilot study to determine the quality and availability of client level records and the collection of baseline data (the pilot study protocol was previously submitted to TMH IRB). Phase 2 will consist of a Knowledge, Perceptions and Information (KPI) intervention during which probation/parole agencies will undergo training to increase knowledge about the effectiveness of MAT, and complete a post training assessment to evaluate the effectiveness of the KPI intervention. During Phase 3, probation/parole agencies will be randomly assigned to a 12-month Organizational Linkage Intervention (OLI) condition or to control (no further intervention). Agencies assigned to the OLI will establish a Pharmacotherapy Exchange Council (PEC) that consists of staff from both the probation/parole and community treatment agencies. The PEC will undergo a strategic planning process to increase the availability of MAT for opiate and/or alcohol dependent individuals who are on probation/parole.

Interventions

OTHERKPI training only

See comparison arm description.

OTHERKPI plus OLI

See experimental arm description.

Sponsors

Arizona State University
CollaboratorOTHER
Friends Research Institute, Inc.
CollaboratorOTHER
National Development and Research Institutes, Inc.
CollaboratorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Temple University
CollaboratorOTHER
Texas Christian University
CollaboratorOTHER
University of California, Los Angeles
CollaboratorOTHER
University of Connecticut
CollaboratorOTHER
University of Delaware
CollaboratorOTHER
University of Kentucky
CollaboratorOTHER
University of Puerto Rico
CollaboratorOTHER
Rhode Island Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

Probation/parole or community treatment agency staff.

Design outcomes

Primary

MeasureTime frameDescription
Opinions About MAT6-month follow-upMeasures knowledge, perceptions, and intentions regarding the use of pharmacotherapy for the treatment of opioid and alcohol dependence. Will be assessed at baseline, post-training, post intervention, and 6-month follow-up.

Secondary

MeasureTime frameDescription
Interorganizational Relationships6-month follow-upWill be assessed at baseline, and post intervention (6-month follow-up).
Referrals to Medication Assisted Treatment (MAT)6-Month Follow-upEstimated numbers of alcohol- and opiate-dependent offenders on Probation/Parole

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026